Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-30 Morgan Adam Director Grant or award +53,960 123,737
2025-08-08 Morgan Adam Director Purchase +1,766,546 $1.50 $2.6M 8,753,290
2025-08-08 Morgan Adam Director Purchase · Series A Convertible Preferred Stock +70,012 $15.00 $1.1M 70,012
2025-01-31 Morgan Adam Director Grant or award +17,950 69,777
2025-01-31 Morgan Adam Director Grant or award · Stock Option (Right to Buy) +35,900 35,900
2025-01-30 Morgan Adam Director Grant or award +17,950 69,777
2025-01-30 Morgan Adam Director Grant or award · Stock Option (Right to Buy) +35,900 $1.73 $62K 35,900
2024-01-19 Morgan Adam Director Grant or award +13,948 51,827
2024-01-19 Morgan Adam Director Grant or award · Stock Option (Right to Buy) +83,685 83,685
2023-07-21 Morgan Adam Director Purchase +2,486,744 $1.37 $3.4M 6,986,744
2023-07-21 Morgan Adam Director Purchase · Pre-funded Warrants to Purchase Common Stock +1,162,891 $1.37 $1.6M 1,162,891
2023-02-22 Morgan Adam Director Grant or award +37,879 37,879
2023-02-22 Morgan Adam Director Grant or award · Stock Option (Right to Buy) +227,272 227,272

Page 1 of 1 · 13 trades